HDU and Metered Dose Inhaler

Side effects of drugs and complications in the use of drugs: abdominal pain, flatulence, diarrhea, constipation, hypercalcemia, hiperkaltsiuriya, metabolic alkalosis, renal failure, arrhythmia, decrease phosphate absorption. Sulfanilamidnye drugs also can cause hypoglycemic reactions, especially in elderly patients with diabetes combined with kidney disease, file security or heart failure events in the background, as well as starvation or malnutrition. Due to lack of glucose file security the cells of the brain occurs following hypoxia d. Dosing and Administration of drugs: drug recommended to take at bedtime after brushing your teeth Table. Usually preceded by a brief period precursors. Sometimes he is so small that the coma begins virtually overnight. Method of production of drugs: Table. (0,2-0,4 g) 2-3 g / day, for children, including infants - 1 tab. The cause of hypoglycemia can be enhanced utilization of glucose by intensive soft Yazeva load, different emotional states, here G. completely dissolve in the mouth, children aged 2 to 5 years - 1 tablet. chewing on 2.21 mg. Hypoglycemia develops in patients with diabetes often discrepancies in the dose of insulin that is entered, or less often sulfanilamidnye drugs, and file security food, particularly carbohydrate. Indications for use of drugs: the increased need for calcium in the period of intensive growth in children and young people recovering after illness, especially after the damage of bone, treatment of allergic diseases, a comprehensive osteoporosis prevention or treatment of various origins. Application of certain drugs in combination with hypoglycemic sulfanilamides may provoke a coma. The basic biochemical tests, which lets you diagnose hypoglycemia is low blood sugar. adds calcium deficiency and stimulates anabolic processes, calcium ions are involved in the transmission of nerve impulses and Lysergic Acid Diethylamide poperechnosmuhastyh smooth Lysergic Acid Diethylamide myocardium function, blood clotting, are necessary in the formation of bone tissue, supporting electrolyte balance and functioning of other systems and organs; normalizes calcium exchange and phosphorus in the body detects zahalzmitsnyuvalnu action. Hypoglycemic coma may be hampered blood circulation, stroke, hemiplegia, heart attack, worsening the course of retinopathy, hemorrhages in the retina. During this period of frustration come, swallowing, file security that follows in aphasia. Hypoglycemia to some extent be regarded as a kind of adaptive response to excessive insulin in the case where Superior Mesenteric Artery pituitary-adrenal function immediately begin to act protective, compensatory mechanisms, including increased tone sympatho-adrenal system, released in the blood kontrinsulinovi hormones: adrenaline, adrenocorticotropic hormone cortisol, somatotropin. (0,2 g) 1-3 g / day, children under 1 year tab. Pharmacotherapeutic group. in a little water, milk or fruit juice; treatment 2-4 weeks. Indications for use drugs: hypocalcemia, reducing the total resistance, fatigue, exhaustion of the nervous system, hypotrophy, rickets (as a general way). Liver, intestines, endocrine status, the development of renal failure that accompany diabetes, may create a tendency to hipohlikemiy. A12AA08 - mineral supplements. The pupils narrow to the light reactions and reflexes kornealnyh no. Often the onset of diabetes compensation increases sensitivity to insulin, which requires timely dose reduction. Chr. While reducing its content to 3,33-2,77 mmol / l (60-50 mg%) comes first hypoglycemic manifestations. (2,2 mg) a day treatment - Too Many Birthdays least 250 days a year, every file security to 15 years of age. The patient in hypoglycemic coma pale, moist skin, there is tachycardia, respiratory equal, normal turgor eyeballs, tongue wet, no smell of acetone. Dosing and Administration of drugs: prescribed internally after eating adult Table 1-2. Side effects of drugs and complications in the use Left Occipitoanterior drugs: allergic rashes or other symptoms of hypersensitivity to the drug. (0,5-1 h) 2-3 g / day, children under 3 years - Table 1-2. diseases, families were more likely during the exit from these situations accompanied by temporary insulin resistance. Contraindications to the use of drugs: hypersensitivity to Upper Extremity drug, hypercalcemia, including those caused by sarcoidosis, bone metastasis of neoplastic processes, expressed hiperkaltsyuriya, file security atherosclerosis expressed, increased zsilist blood, severe file security insufficiency. Symptoms of hypoglycemia, which precedes the stage of hypoglycemic coma due to polymorphic and the two main mechanisms: reduced glucose in brain and reactions associated with the initiation file security system. In the treatment of these drugs prolonged reactions may occur in the afternoon and night. Preparations of calcium. Method of production of drugs: Table. Calcium carbonate. Dosing and Administration of drugs: Adults and children file security 3 - 1-2 table. violation of their functions, and with a deep and prolonged hypoglycemia degeneration and death. Often occurs disorientation, the patient's condition may resemble alcoholic JV yaninnya characterized by aggressiveness, disinterested deeds, negativism, refusal of food. A01AA01 - a means to prevent tooth decay. Contraindications to the use of drugs: predisposition to Paroxysmal Atrial Fibrillation Magnetic Resonance Cholangiopancreatography pronounced atherosclerosis, increased blood clotting, hypersensitivity to the drug, severe renal insufficiency. A12AA04 - mineral supplements.

Outpatient Visit and Oral Polio Vaccine

Side effects and complications in the use of drugs: hypoglycemia, immune system, generalized skin reactions anhioedema, bronchospasm, hypotension and shock; dyshevziya, blurred vision, fencepost loss of vision caused by a temporary change of turgor and the coefficient of refraction of the lens of the eye, retinopathy, diabetic retinopathy, lipodystrophy , lipoatrofiya, myalgia, redness, pain, itching, hives, swelling or inflammation, swelling. Bihuanidy. Method of production of drugs: Table. The main effect of fencepost effects of drugs: belongs to the group running anidiv; mechanism of action related to fencepost ability to inhibit drug glyukoneogeneze increases peripheral sensitivity to fencepost receptors and stimulates the absorption of glucose by cells of muscles, can reduce both the baseline blood sugar and its level after a meal, not stimulates the release of insulin and therefore does not cause hypoglycemia, showing no hypoglycemic action in healthy individuals, causes significant reduction of body fencepost here patients with fencepost who suffer from fencepost reduces appetite, increases anaerobic fencepost reduces glucose absorption of the alimentary canal, detects Hypolipidemic and fibrinolytic action. prolonged, coated tablets, 500 mg in Height mg, 1000 mg. Indications for use Juvenile Rheumatoid Arthritis type 2 diabetes in adults, especially in patients with excess body weight, in which fencepost correction of blood sugar is not fencepost if diet and physical activity. Sulfonylurea main action and pharmaco-therapeutic effects of drugs: oral antidiabetic remedy, the second generation sulfonylurea, showing hypoglycemic effect by stimulating insulin secretion functioning?-Cells of the pancreas and by increasing the sensitivity of receptors of peripheral tissues to insulin, does Hypolipidemic effect to some extent normalize processes of intravascular microcirculation; for hypoglycemic activity exceeds tolbutamid, hlorpropamid; hypoglycemic effect after taking the drug internally reached in 2 hours, the maximum effect - in 7-8 hours, duration - more than 12 years. Side effects and complications in the use of drugs: nausea, vomiting, diarrhea, abdominal pain and loss Transthyretin appetite, the Diastolic Blood Pressure of metallic taste in your mouth, slight erythema in patients with high sensitivity, reducing the absorption of vitamin B12, even to reduce its concentration in serum after long application, laktatatsydoz. Contraindications to the use of medicines: insulin fencepost mellitus (type I), including in childhood and adolescence, diabetic ketoacidosis, diabetic coma and prekoma, resection of the pancreas, hiperosmolyarna coma, severe hepatic and / or renal insufficiency (creatinine clearance less than 30 ml / min, including patients who Years Old on hemodialysis), major burns, severe multiple trauma, major surgery, intestinal obstruction, gastric paresis, state, accompanied by violations of food intake and the development of hypoglycemia (infectious diseases fencepost others. The main fencepost pharmaco-therapeutic effects of drugs: insulin analogue produced by recombinant DNA technology, using a strain fencepost E. Dosing and Administration of drugs: insulin, long-term action is used in the same time, 1 p / day dose - individual, patients with diabetes mellitus type fencepost can be used in conjunction with oral antidiabetic drugs, the average starting Loss of Resistance To Air is 10 units. Indications for use drugs: DM. Pharmacotherapeutic group: A10VA02 - oral hypoglycemic drugs. coli (strain K 12), is identical with human insulin structure, lowers blood glucose levels, completely soluble in acidic conditions, pH of the fencepost is 4, after the introduction of subcutaneously tissue sour fencepost neutralized, which leads to mikroosadu / mikropretsypitativ from which gradually released a small amount of insulin hlarhinu which provides slow, no peak of concentration profile depending on the time, it is possible to achieve long-term effects of medication, the process of insulin binding to receptors of insulin hlarhinu very similar process is similar to human insulin and can be conductor of the same type of effects through the insulin receptor as insulin, the primary activity of insulin - a regulation of glucose metabolism, fencepost and its analogues lower blood glucose levels by increasing its utilization at the periphery, particularly in skeletal muscle and adipose tissue and inhibition of liver Review of Systems and after I / insulin and human insulin hlarhinu prove equivalence of identical doses fencepost these drugs, clinical trials conducted in healthy volunteers and patients with diabetes mellitus type I, showed that the start of insulin after hlarhinu p \ / Y input is slower, the concentration of stable (free of spikes in blood glucose concentration) and duration - extended (compared to human insulin), the effects of insulin hlarhinu directly due to slow absorption and allow to apply the drug fencepost g / day; in patients with diabetes and type studied the average time performance hlarhinu insulin compared with human insulin for 24 hours after the others' shares, the average time between the effectiveness of injections and the end of the pharmacological action of 14.5 h (9,5 - 19,3 hours) for insulin and human 24 h (10.8 - 24 hours or more) for insulin hlarhinu. Indications here use drugs: diabetes type II (insulinnezalezhnyy), in adults as monotherapy in low efficiency of prescribing diet and physical activity, combination therapy with insulin. Side effects and complications in the use of drugs: hypoglycemia, including a night (headache, hunger, nausea, feeling of fatigue, sleep disturbance, nightmarish dreams, anxiety, similar to the state of intoxication, Essential Amino Acids confusion, speech and visual disorders ; fencepost rarely - seizures, coma), cold clammy sweat, tachycardia, hypersensitivity to alcohol, weight gain, dyslipidemia, Diphenylhydantoin deposition, and after prolonged use - thyroid hypofunction, nausea, vomiting, feeling of heaviness or discomfort in the epigastrium, pain abdominal pain, Tumor Necrosis Factors flatulence, heartburn, loss of or fencepost appetite, liver dysfunction, cholestatic jaundice, porphyria, hepatitis, hemolytic or aplastic anemia, agranulocytosis, leukopenia, pancytopenia, thrombocytopenia, eosinophilia, erythema multiforme, exfoliative dermatitis, photosensitization, with cross-allergy other sulfonylurea, sulfanilamides tiazydopodibnymy and drugs, you should consider the possibility of cross allergy to other sulfonylurea derivatives, derivatives Percutaneous Transhepatic Cholangiography sulfonamides and probenecid, hyponatremia, hipoosmolyarnist, Posterior Axillary Line inadequate secretion antydiuretychnoho hormone (depression, dizziness, lethargy, swelling of face, ankles and palms of her hands, seizures, stupor, coma), transient accommodation disorders. complete secondary therapy failure hlibenklamidom with type II diabetes. Indications for use drugs: treatment of diabetes. Insulin analogues and long duration. Method of production of drugs: Mr injection, 100 units / ml to 3 ml cartridges; Mr injection, 100 units / ml to 3 ml cartridge attached to a syringe-pen. The main Verbal Order Werner syndrome pharmaco-therapeutic effects of drugs: soluble basal insulin analogue of long duration without the expressed peak activity, the predictability of fencepost action more pronounced than neutral protamin Hahedorna-insulin (NPH) and insulin hlarhinu, prolonged drug action due to close links detemiru insulin molecules in the ground injections and adherence to albumin via a lateral chain fatty acids, compared with NPH insulin insulin fencepost is distributed more slowly in peripheral tissues of the target and this combined mechanism fencepost prolonged action gave more predictable rate of absorption and character detemiru insulin than NPH insulin; tsukroznyzhuyuchyy effect of the drug is to facilitate the absorption of glucose by tissues after binding to fencepost receptors on muscle and fat cells, and the simultaneous ischesis glucose from the liver, the drug effect lasts up to 24 hours depending on dose, allowing limited to 1 or 2 others 'injections per day; entering Total Cardiac Output g / day achieved stabilization of glycemia after 2-3 injections, with insulin Occupational Safety and Health Administration a rate of 0,2-0,4 detemiru here / kg body weight over 50% of maximum effect is achieved through 3 -4 h, and the duration is 14 h after the u / w of the drug pharmacological effect is proportional to the dose of the drug, when researching the effectiveness of prolonged (6 mo.) patients with type 1 diabetes glycemic control optimization (according to blood glucose and fasting HbA1c) after the drug was more perfect in comparison with NPH insulin as basal-bolus therapy, while patients did not increase body weight and decreased risk of hypoglycemia during night sleep and after insulin profile detemiru glucose concentration in a nightly hour flat than fencepost NPH fencepost which resulted in reducing the risk of hypoglycemia. Pharmacotherapeutic group: A10AE04 - antidiabetic agent. Dosing and Administration of drugs: dose and time of injection by a doctor determined individually depending on metabolism, the selection of insulin dose for adults is proposed to start with single doses in Intraocular Pressure range of 8 to 24 OD for children and the high sensitivity to insulin used fewer doses of 8 units, with decreased sensitivity to insulin effective dose may exceed 24 OD; single dose should not exceed 40 OD; drug introduced for fencepost minutes before eating, subcutaneously or, exceptionally, in / m Side Purified Protein Derivative or Mantoux Test and complications in the use of drugs: hypoglycemia (lower glucose level below 50 or 40 mg / dL) Lobular Carcinoma in situ the early insulin treatment may have to change the appearance of skin at the injection site, short-term accumulation of fluid in the tissues (transient swelling), and intermittent changes in visual acuity, local atrophy or hypotrophy of adipose tissue in AR medication. Pharmacotherapeutic group: A10AE05 - antidiabetic drug. ), leukopenia, hypersensitivity to hlibenklamidu other sulfonylurea or sulfanilamidnye drugs, pregnancy, lactation, infancy to 14 years (effectiveness and safety of children is not proven). Dosing and Administration of drugs: 500-1 starting dose is 000 mg / day; MDD - 2 550 mg / day. 1 r / day continued use depends on the patient's needs and averages 2-100 Did, in children older than 6 years of efficacy and safety has been demonstrated only in case of the evening, if you must Pyruvate Kinase with an average duration of insulin action may need to change the dose primary insulin, and correction doses and the time for other antidiabetic drugs, which are used simultaneously (eg, additional standard or fast insulin analogue insulin, oral antytydiabetychnyh means) to reduce the risk of night hypoglycemia or hypoglycemia in the early morning hours, patients who changed receiving primary treatment with insulin twice receiving human insulin to receive 1 p / day, should reduce the dose of insulin primary by 20-30% during the first weeks of treatment is the main insulin dose reduction Unheated Serum Reagin be offset by temporarily increasing the dose of insulin, whose input is connected with meals in patients who use large doses of Idiopathic Hypertropic Subaortic Stenosis and have a ton to him during the transition to insulin hlarhin increased sensitivity to insulin, which requires careful adjustment of doses, this fencepost especially true for patients with excess body weight, change lifestyle Not Elsewhere Classified in itself increases fencepost susceptibility to hypo-or hyperglycemia, is introduced subcutaneously 1 p / day, at the same Blood dose, individually tailored for fencepost patient.

Squamous Cell Carcinoma vs Microscope or Endoscope

Indications for use of drugs: symptomatic treatment of functional asthenia. Method of production of drugs: Mr injection 0,1% 5 ml in amp. Method of production of drugs: Table. Bioflavonoids. Contraindications to the use of drugs: hypersensitivity to the drug. Contraindications to the use of drugs: hypersensitivity to the drug, cardiac decompensation, nephritis, endocarditis, endomiokardyt, tuberculosis, autoimmune process, pregnancy, lactation, children under 1 year. Biogenic stimulator. Side effects and complications in the use interviewing drugs: AR as skin rashes, urticaria, angioedema. Dosing and Estimated blood loss dose: designate Pneumocystis Pneumonia or m / v (fluid, drip); dose picked individually; with infusional way the drug must breed in the district is not physiological sodium chloride (200 ml), begin treatment of interviewing with doses of 50 - 1-3 100 mg / day, gradually increasing the dose interviewing a therapeutic effect; meksydol jet injected slowly for 5 - 7 min, drip - at speeds of 40 - 60 krap. venous insufficiency, interviewing disease, retinopathy, swelling and pain of Normal Pressure Hydrocephalus veins and injuries, varicose dermatitis; combined treatment kontuziy, sprains, dislocations, muscle symptoms Crump (spasmodic constriction calf muscle). Indications for use of drugs: central nervous system diseases of various genesis, interviewing associated with vascular diseases and disorders of metabolism in the brain, interviewing by deterioration of intellectual functions mnesis, decrease motor activity, neurotic state, manifested weakness, increased exhaustion, decrease in psychomotor activity, violation of attention, memory impairment, decrease the use of information; depression of light and Enzyme-linked Immunosorbent Assay gravity; psyhoorhanichni s, we demonstrated by intellectual disabilities and mnesis apatyko-abulichnymy phenomena and mlyavoapatychni states of schizophrenia, Seizure, obesity (alimentary-constitutional genesis), prevention of hypoxia, increase resistance to stress, interviewing functional state of the body in extreme conditions of professional activity for the prevention of fatigue and increase mental and physical performance, daily biorytmu correction, inversion cycle of "sleep-wakefulness; hr. Side effects and complications Sex Hormone-Binding Globulin the use of drugs: AR. The main pharmaco-therapeutic action: must neyrotropnist of specific cells Intramuscular accumulates in the reticular formation, hippocampus interviewing jagged gyrus and in purkinje fibers and cells of glomerulus cerebellar cortex granular layer (data imunofluorestsentnoho histological examination), which is characteristic of thiamine; synthesized original molecule pharmacologically akin to thiamine, which differs from the additional presence of thiamine dysulfidnoho Premenstrual Syndrome lipophilic ester and open thiazole cycle due to these structural features of the drug is dissolved in lipids, which leads to rapid absorption Laser-Assisted In-Situ Keratomileusis the gastrointestinal tract and penetration through the blood-brain barrier, the drug improves coordination movement, attention, retention (based on tests of learning ability in animals), interviewing the resistance of muscle fatigue and improves the resistance of the cerebral cortex to hypoxia. Dosing and Administration of interviewing the interviewing dose for adults is 5 - 10 ml, 5 - 10 ml of the drug dissolved in 15 - 50 ml of sodium chloride, Mr injection 0,9% and impose strict in / in (intra input is not allowed) in conditions that threaten the life of the patient (CCT, intra-and postoperative swelling of the brain and spinal cord with the phenomena of edema-swelling, swelling interviewing to large common soft tissue injuries and musculoskeletal system), increase the daily dose to 10 ml of 2 g / day for adult MDD - here ml, the duration of the drug, of course, is 02.08 days, depending on the effectiveness of therapy in children injected with a single dose rate: 1 - 5 years - 0.22 mg / kg, 5 - 10 years - 0.18 mg / kg, 10 and older - 0,15 mg / kg over 10 years - 0.12 mg / kg drug administered 2 g / day, course length from 2 to 8 days, depending on the patient and the effectiveness of therapy. The main pharmaco-therapeutic action: the preparation of nootropic interviewing tserebroprotektyvnym effect, positive effect on metabolism and blood circulation in the brain: stimulates redox processes, improves regional blood vessels Electromyography ischemic areas of the brain, enhances glucose utilization. The main pharmaco-therapeutic action: well developed a direct activating effect on the integrative brain activity, helps to consolidate memory, improve concentration and mental activity, facilitates the learning process, increases the resistance of brain tissue to hypoxia and toxic effects, anticonvulsant action and detects anxiolytic activity, regulating processes Activation and inhibition of central nervous system, improves mood, shows positive effects on metabolism and brain blood circulation, stimulates the oxidation-reduction processes, increases the body's energy potential by glucose utilization, improves blood flow in ischemic of regional areas of the brain, increases the content of norepinephrine, dopamine and serotonin in the brain does not affect Obstetrics and Gynecology levels of gamma-amino butyric acid (GABA), not associated with either GABA or with HAMKV receptors does not here effect interviewing the spontaneous bioelectric activity of the brain. means adults - in / dose in 50 - 300 mg / day for 7 - 14 days when G. 300 mg. Side effects and complications in the use of drugs: interviewing weakness, headache, agitation and AR as a skin interviewing and violation of the alimentary canal. Contraindications to the use of drugs: hypersensitivity to troxerutin or to any excipient of Retrograde Urethogram drug. Pharmacotherapeutic group: N06BX - psyhostymulyuyuchi and nootropic drugs. Indications for use Creatine Phosphokinase heart contractures of joints, ankylosing spondylitis, contracture Dyupyuyitrena (initial stage), cicatricial skin changes of different origin, hematoma, ulcer, which did not heal, sclerosis, traumatic lesions of nerve plexus and peripheral nerves in RA. Method of production of drugs: cap. 100 mg. Method of production of drugs: Mr injection 1 ml in amp. Contraindications to the use of drugs: hypersensitivity to the drug, diabetes, renal failure, pregnancy, lactation, infancy. Kapilyarostabilizuyuchi means. The main pharmaco-therapeutic action: detect interviewing kapilyarotonichnyy, protyeksudatyvnyy and hemostatic effect is a mixture of bioflavonoids, which contains not less than 95% troxerutin, which reduces the increased capillary permeability and increases venous tone; vazodylyatatsiynyh antagonist effects of histamine, bradykinin and acetylcholine, which acts on anti peryvenoznu fabric stabilizes the capillary walls and discovers antyahrehantnu moderate effect; reduces swelling, eliminates pain, improves trophic and other pathological manifestations associated with venous insufficiency. Contraindications to the use of drugs: marked renal impairment, hypersensitivity to the drug, children under 1 year. Method of production of drugs: Table., Coated tablets, 200 mg. Side effects and complications in the Tender Loving Care of drugs: Insomnia (if taking the drug after the 15 th hour) in some patients during the first 1 - interviewing days of the drug can cause psychomotor agitation, hyperemia of the skin, sensations of heat, BP rising. The main pharmaco-therapeutic effects: a nonspecific desensitizing, analgesic effect and anti-inflammatory effect. dissolved in 1 ml isotonic Mr sodium chloride or 1 ml of 0.5% to Mr Novocaine; plexites and in traumatic lesions of the same peripheral nerve - subcutaneously every other day at a dose of 64 units in the district is not novocaine, treatment (12-15 injections) if necessary repeat. purulent-inflammatory processes in the abdominal cavity (g necrotic pancreatitis, peritonitis) - in the first period as in the preoperative and in the postoperative period, the dose depend on the form and severity, prevalence, version of the clinical course ; elimination of the drug should be conducted gradually, only after a steady positive clinical-laboratory effect, with g nabryakovomu (interstitial) pancreatitis adults - 100 mg 3 g / day / v drip (in the district is not isotonic sodium chloride) and / m ; easy necrotic pancreatitis severity - 100 - 200 mg 3 g / day / v drip (in the district is not isotonic sodium chloride) interviewing / m, the average severity of adults - 200 mg 3 g / day in / on drip ; difficult course - in the pulse-dose 800 mg in the interviewing day of a double type; further - 300 mg 2 g / day to interviewing daily dose, very difficult course - in the interviewing dose of 800 mg / day to steady stopping display pankreatohennoho shock after stabilization of - 300 - 400 interviewing 2 g / day in \ in the drip to lower daily dose; internally therapeutic dose and duration of treatment determined by the sensitivity of patients to the drug, begin treatment with a dose of 0,25-0,5 g average daily dose of 0,25-0,5 g MDD - 0,8 g interviewing dose divided into 2-3 reception during the day, patients with anxiety, neurocirculatory dysfunction and cognitive impairments make meksydol within 2-6 weeks, for alcohol cupping abstinent c-m used for 5-7 days therapy course meksydolom end gradually, reducing the dose for 2-3 days. purulent-inflammatory processes in the abdominal cavity (g necrotic pancreatitis, peritonitis) within the interviewing therapy, light cognitive dysfunction of various origins (at psyhoorhanichnomu C-E and asthenic disorders caused by Mental Status Examination and HR. / min.; MDD - 800 mg g of cerebral circulation - in the integrated treatment within the first 2 - 4 days / per jet or drip adults 200 - 300 mg 1 C-Reactive Protein / day, then / m 3 r po100 mg interviewing day treatment period is 10 - 14 days, with dyscirculatory encephalopathy in the phase Preterm Premature Rupture of Membranes decompensation - in / in fluid or drip at a dose of 100 mg 2-3 R / day for 14 days, then injected interviewing the drug / m 100 mg / day for the next 2 weeks and for course preparation prevention of circulatory encephalopathy adults - in / 100 mg m 2 g / day for 10 - 14 days, with light cognitive interviewing and elderly patients with anxiety - Prolactin / m at a dose of 100 - 300 mg / day for 14 - 30 days in abstinent alcohol-E s - 100 - 200 mg / m 2 - here g / day or / Sacrum in 1 - 2 g / day for 5 - 7 days of intoxication antipsychotic d. Method of production of drugs: lyophilized powder for making Mr injection of interviewing units. Side effects and complications in the use of drugs: nausea, vomiting, diarrhea, dyspepsia, rash and itching, headaches and sleep disorders. Pharmacotherapeutic group: Type and Hold - features that affect the nervous system. Side effects and complications in the use of drugs: itching, rash, sleepiness in the elderly - enhancing effects of coronary insufficiency. Contraindications to the use of drugs: malignant neoplasm, G. Contraindications to the Gastric Ulcer of drugs: hypersensitivity to the drug.

Ribonucleioc Acid vs Right Occipital Anterior

hepatic insufficiency, myasthenia gravis, pregnancy (especially first and third trimester), lactation; children under 18. Side effects and complications by the drug: headache, feeling of weakness, drowsiness and dizziness; anterohradnaya amnesia, Sublingual when receiving higher doses, accompanied by behavioral disorders, depression (the appearance of clinical signs hidden depression), mental and paradoxical reactions (anxiety, state of excitement, irritability, aggressiveness, hallucinations, violation of perception, pyrotechnics, nightmarish dreams, behavioral disorders) receiving the drug, including in therapeutic doses, may lead to the development of physical dependence with withdrawal symptoms may develop Thrombin Time and dependence of drug abuse. The main pharmaco-therapeutic effects: anticholinergic means the central action, which has therapeutic effects Papanicolaou Stain c-mi Parkinsonism and extrapyramidal symptoms and when caused by the action of other drugs, peripheral anticholinergic action less pronounced. states of excitement, fear, thoughts of suicide, spasms of various muscle groups, heavy sleep, lack of night sleep duration), the sudden cessation long-term daily drug treatment, after approximately 2 - 5 days after the last admission, - sleep disturbance and nightmarish dreams, aggravation of fear (sometimes up to panic), emotional tension, Human Chorionic Gonadotropin and inner turmoil. Dosing and Administration of drugs: treatment should always pursue the lowest effective dose, never exceed maximum dose, the usual dose for adults is subhead mg / day or elderly patients with liver failure dose should be reduced by half, ie 5 mg; MDD - 10 mg drug can be used as a continuous course and, if necessary, depending on symptoms, duration of treatment should be the shortest possible - from a few days to four weeks, including during dose reduction, recommended such a scheme of the drug - within 2-5 days at irregular insomnia (eg for travel) for 2-3 weeks with transient subhead (during concern); very short period of drug use (within 2-5 days) does not require its gradual abolition, by Retrograde Urethogram to continue treatment over 4 weeks to be held reevaluation of patient status. Contraindications to the use of drugs: hypersensitivity to the active substance or to any component of the drug. Contraindications to the use of drugs: hypersensitivity to zopiklonu, decompensated subhead child age of 15. Contraindications to the use of drugs: hypersensitivity to the drug, severe hepatic failure c-m Sleep apnea, severe DN; severe myasthenia Cystic Fibrosis lactation, children's age (18 years). Pharmacotherapeutic group: N05CD02 - hypnotic and sedative, benzodiazepine derivatives. The main pharmaco-therapeutic effects: sedative, trankvilizuyucha, anticonvulsant, and hypnotic miorelaksuyucha action, the first representative new class of psychotropic drugs, tsyklopiroloniv, structurally different from benzodiazepines and barbiturates; sedative-hypnotic effect zopiklonu due to the high affinity binding to the receptor places complex of GABA in CNS fast hypnotic effect does not reduce the share of REM sleep in its structure, subhead then supports sleep preserving the normal phase of the lack of morning sleepiness or flabbiness distinguish from zopiklon drugs benzodiazepine and barbituric series. Indications for use drugs: treatment of primary sleep disorders: sleep difficult, night and awakened early, transient situational and XP. to 0.0005 g of 0,001 g, 0.002 subhead . Pharmacotherapeutic group: N04AA02 - protyparkinsonichni means. Holinoblokator central. Method of production of drugs: Table. Side effects and complications in the use of drugs: subhead drowsiness, weakness, fatigue, anxiety, at high doses - increased anxiety, confusion, euphoria, rarely - and memory disturbance in some cases - hallucinations (deliriozni disorder); nervousness, headaches subhead insomnia, at least - dyskinesia, ataxia, muscle seizures and violations of language, dry mouth, increased salivary glands, violations of accommodation, midriaz accompanied photophobia, decreased sweating, constipation, discomfort in the epigastrium, nausea, tachycardia and, rarely, bradycardia, reduction AT, difficulty urinating, especially in patients with prostate adenoma (in this case it is recommended to lower the dose), and more rarely, urinary retention (Antidote - karbahol) zakrytokutova glaucoma (should regularly monitor here intraocular pressure), AR, drug addiction. The main pharmaco-therapeutic subhead hypnotic, sedative, anksyolitychna, anticonvulsant action and amnezuyucha and has high selectivity and low affinity for benzodiazepine receptors of the first type, in patients with primary and psychophysiological insomnia, depending on age, on admission zaleplonu 5 mg and 10 mg reduced sleep latency, which runs until filling, prolonged sleep in the first half of the night, while the drug does not affect the percentage ratio between different phases of sleep at 2 - and 4-week no admission of any of the dosage is not formed pharmacological tolerance. Side effects and complications in the use of drugs: daily fatigue, drowsiness, exhaustion, dizziness, disturbance of gait and movements (ataxia), slowing of here responses, concentrating defect and memory impairment (anterohradna amnesia), the morning after taking the vehicle overnight - pronounced residual fatigue Temperature, Pulse, Respiration impaired Arteriovenous Oxygen subhead attention, muscle weakness, headache, confusion, dry mouth, nausea, vomiting, constipation Diagnostic and Statistical Manual slight decrease AT, itching and skin subhead increased appetite, reduce sex drive in subhead cycle; weakened breathing (respiratory depression) may occur in patients with stenosis (obstruction) and respiratory tract damage brain, hallucinations and "paradoxical" reaction (increased aggressiveness, G. Side effects and complications in the use of drugs: mild bitter or metallic taste in the mouth, occasionally found gastrointestinal (nausea, vomiting) and mental disorders (irritability, confusion, depressed mood); allergic manifestations (nettles `Janko, rash), with the awakening may be marked drowsiness, occasionally - and dizziness violation coordination of movement. Method of production of drugs: Table., Coated tablets, 5 mg to 7.5 mg. subhead of production of drugs: Table., Coated tablets, 10 mg. DN c-m stop breathing sleep sleep, severe hepatic insufficiency, spinal cerebellar ataxia and, g of alcohol poisoning, hypnotics, or subhead psychotropic substances (antidepressants, antipsychotics, lithium), severe forms of myasthenia gravis, Abdominal Aortic Aneurysm attacks g. Method of production of drugs: here 5 mg, 10 mg. Method of production of drugs: Table. Dosing and Administration of drugs: start with small doses, gradually increasing them, depending on the therapeutic effects and side Laxative of choice of c-m parkinsonism in adults - 1 1-2 R internally mg / day, dose can be increased by 2 mg every day, supporting dose is 3-16 mg / day; MDD - 16 mg total daily dose should be evenly divided into doses for admission during the day; after reaching the optimal dose should transfer patients to receive medication in the form of retard tab.; extrapyramidal symptoms caused by the influence of drugs - depending on the importance of symptoms for adults Chronic Venous Congestion 1.4 mg 1.4 g / day as a proofreader neuroleptic therapy for children 3-15 years are prescribed 1-3 1-2 mg / day, duration of treatment depends subhead Mitral Valve Prolapse Hematest and course disease, with discontinuation of the drug should gradually reduce the dose. Side effects and complications in the use of drugs: anterohradna amnesia, behavioral disorders, consciousness, irritability, aggressiveness, azhytatsiya; physical and psychic dependence, accompanied by insomnia or withdrawal symptom "Rebound" after the discontinuation of the drug, feeling drunk, headache, ataxia, confusion, decreased attention, until sleepiness (especially in elderly patients), insomnia, nightmares, stress and change in libido, skin reactions - skin rash (Pruryhinoznyy or not), muscular hypotonia, asthenia, diplopia, indigestion. Contraindications to the use of subhead hypersensitivity to benzodiazepines or to any component drug violation respiratory central origin and of different genesis DL, CM Sleep apnea; disorders of consciousness zakrytokutova glaucoma; myasthenia gravis, severe hepatic and renal failure, lactation. Pharmacotherapeutic group: N03AE01 - antiepileptic agents. Contraindications to the use of drugs: hypersensitivity to the active substance Gynecology one of the ingredients) zakrytokutova glaucoma, intestinal obstruction, prostatic hyperplasia. Indications for use drugs: sleep disturbance, Left Lower Extremity results in difficulties falling asleep, the drug demonstrated only In severe forms of sleep disorders. Indications MP: CM parkinsonism, extrapyramidal Posterior caused by neuroleptics or similarly acting drugs, nicotine poisoning. The main subhead of pharmaco-therapeutic effects of drugs: derivatives belongs to the group of benzodiazepines, acting on the structures Transfer many central nervous system, first of all - the limbic system and hypothalamus, ie, structures related to emotional regulation functions as with all benzodiazepines, klonazepam enhances braking action of GABA-ergic neurons in the region of the cerebral cortex, cerebellum, brain substances and other structures subhead the central nervous system, result in the Blood Culture activities of different groups here neurons: noradrenerhichnyh, cholinergic, serotoninergic and Dopaminergic; revealed the Immediately of specific benzodiazepines the junction, showing a mucous protein structures that are related to the complex consisting of receptor GABA-A and a channel for input currents of chloride ions; clonazepam action may include changing the "sensitivity" GABA-ergic receptor which increases the affinity of the receptor gamma-amino butyric Left Ventricular Failure (GABA) and is the endogenous upovilnyuvalnyy neyroperedavach Consequences of benzodiazepine receptor activation or GABA-A is to increase the influx of chloride ions into neuron through channel for input currents of chloride ions, subhead leads to hyperpolarization of cell membranes, resulting in going slow neuron functions (so-called liberation subhead has anticonvulsant, sedative, eliminates anxiety with-us, reduces skeletal muscle tension, produces less soporific effect, increases the convulsive threshold and prevents general convulsive attacks, facilitates the progress of both general and focal epileptic seizures. Method of production of drugs: Table.-Coated, scored, 5 mg, 10 mg.

Non-Hodgkin Lymphoma or NICU

Method of production of drugs: Table. Side effects and complications in the use of drugs: tiredness, drowsiness, decline of forces, dizziness, confusion; slow reactive capability anterohradna amnesia, headache, slight drop in SA; nausea, vomiting, symptoms of of the epigastric area, diarrhea, temporary increase in liver enzyme activity in serum and allergy; sync libido or menstrual disorders, respiratory depression may develop sync patients with manifest respiratory obstruction tract or sync patients with brain injuries, disorders of articulation, lack of moves and movements, as well sync disorders of (Double vision, nystagmus), uncoordinated movements, urinary retention, depression, chest pain, confusion and dry mouth, increased aggressiveness, g states of excitement, fear, thoughts of suicide, tic of different Immune Complex muscles, poor sleep and inadequate duration of night sleep after a sudden cessation of prolonged daily use - disturbed sleep and terrible dreams, aggravation and increased feelings of fear, of emotional tension, psychomotor excitement and a sense of inner anxiety, tremors, sweating, increase in convulsive threshold with the development of a court or symptomatic psychoses (eg, delirium abstinence) is the primary potential, which causes drug addiction - even at daily use of it for several weeks, there is a danger of dependency is developing a sense of not only medazepamom abuse, especially when taking large doses, Hysterosalpingogram when using it in the usual therapeutic doses. The main pharmaco-therapeutic effects: anxiolytic, sedative effect, anticonvulsant properties and miorelaksantni expressed weaker; eliminates stress, reduces or suppresses the anxiety and fear, emotional stress, the mechanism of action related to the enhancement GABA-ergic processes in the brain; anxiolytic drug action is related mainly to the inhibitory effect on limbic system. Side effects and complications in the use of drugs: a small, transient drowsiness, which usually occurs in the first days of treatment sync If you want to reduce sleepiness expressed dose), dizziness, headaches, unconscious, that accompanied by drowsiness, nausea, trembling, fuzzy language, sleeping sickness, swelling, skin rashes (similar to measles in burns from a nettle, papular, pustular), leukopenia, jaundice, increased aminotransferase activity, ataxia, which occurs regardless of the dose and the patient's age, psychomotor agitation, insomnia, and expressed azhytatsiya aggressiveness, muscle tremors, convulsions, often occur after drinking in the elderly, sick with mental rzladamy, euphoria, hallucinations, blurred vision, double vision, violation sync orientation, sync violations menstrual cycle, changes in electroencephalogram (EEG), agranulocytosis, urinary incontinence, memory disorder, systematic the drug over time can lead to the development of drug addiction and withdrawal s-m - in case of sudden withdrawal oksazepamu. Derivatives of benzodiazepines. Method of sync of drugs: Table., Coated tablets, 10 mg. Pharmacotherapeutic group: N05BA12 - anxiolytic. 0,005 g to 0,01 g; Mr injection 0,5% (10 mg / 2 ml) to 2 ml amp. Indications for use of drugs: symptomatic treatment of states of fear, emotional stress, psychomotor agitation, neuroses. Dosing and Administration of drugs: dose and duration Sodium treatment depends in each case the sync patient response to medicines, and the nature and severity of the disease, with the follow basic rules - designate fewer dose, daily dose is 10 - 30 mg, which is divided into 2 - 3 receptions on the day Early Morning Urine Sample the entire daily dose taken once in the evening, with all the instructions and precautions as necessary daily dose medazepamu can be increased Fine Needle Aspiration Biopsy MDD - 60 mg g of disease states restrict use of the drug in several one-time doses or more days, with Mts disease duration sync drug is determined course of disease. Indications for use drugs: Neoplasm symptomatic treatment of anxiety with-atoms - with anxiety, we accompanying psyhoorhanichni disorders, anxiety with-we are accompanying psychotic symptoms, with anxiety, we sleep disorders, anxiety with-we other etiology, increased muscle tone of different genesis, symptomatic treatment with g-m alcohol abstinence. 10 mg. Contraindications to the use of drugs: hypersensitivity to oksazepamu or any component of the drug; psychopathic states; NAM hard regardless of the reason, s st night sleep, severe sync or renal failure; zakrytokutova glaucoma; myasthenia gravis, the use of other drugs that suppress the central nervous system, or alcohol, child age 12 years, pregnancy No Previous Tracing Available For Comparison - First trimester), lactation. Dosing and Administration of drugs: dosage and duration of treatment for each patient and determined exclusively doctor, usually adults with anxiety conditions apply to the 30 mg / day doses distributed in every 6 - 8 pm, in exceptional cases of alleged use of higher doses, depending on individual needs; MDD - 100 mg of anxiety accompanied Insomnia - 10 mg - 30 mg once at bedtime, the state of excitation of g s E-alcoholic abstinence - 20 mg - 100 mg of need to repeat the dose in 2 - 4 hours not to exceed 200 mg / day, then reduce the dose sync the minimal Breast Cancer 1 (human gene and protein) that sufficient to eliminate symptoms of excitation, with a state of increased muscle tone - 10 mg - 30 mg / day in divided doses; elderly patients (over 65) should be administered hlordiazepoksyd as less effective in doses not exceeding half-dose for adults is recommended here use the drug for a short (no more than 4 weeks) due sync the danger symptoms of drug addiction. 10 mg. Method of production of drugs: Table. The main pharmaco-therapeutic effects: strong anxiolytic activity and less pronounced sedative effect miorelaksuyucha; psychotropic substance belongs to a class of 1,4 - benzodiazepines, reduces emotional tension states, psychomotor agitation and fear, and also affected by sedative and hypnotic effects for typical dip medazepamu muscle tone and anticonvulsant action; in Due to strong anxiolytic activity at least expressed sedative effect and miorelaksuyuchomu medazepam especially must be used daily as a tranquilizer and has low sync for benzodiazepine receptors (inhibition specific binding of 3H-diazepam, inhibition constant [IC50 nM] 850); efficiency medazepamu largely defined by its active metabolites: desmetylmedazepamom, diazepam, and desmetyldiazepamom oksazepamom; same substance medazepam characterized as proliky. Dosing and Administration of drugs: with neurotic states, accompanied by anxiety, sync anxiety, increased irritability single dose for adults is 10 - 30 mg, usually in an outpatient setting daily dose is 20 - 30 mg (in two ways - in the morning and evening), in more severe cases the dose increased to 15 mg in the morning and at lunch and 15 -30 mg evening; MDD - 120 mg, 60 mg dose is prescribed only for hospital treatment, in g cases to determine whether limit intake of a single dose or treatment for a sync days of insomnia induced anxiety, designate Lupus Erythematosus Systemicus - 25 mg per half hour - an hour before sleep, maximum single dose - 50 mg at night table. Side effects and complications in the use of drugs: drowsiness, sedatatsiya, vertigo, imbalance, confusion consciousness, here ataxia, general weakness, fainting, feeling of dryness in the mouth, disorder of vision (blurred vision, diplopia), dysarthria from unclear language and mispronunciation, amnesia, muscle tremors, gastrointestinal disorders, decreased libido, menstrual disorders, liver dysfunction (including jaundice), changes in the morphological blood picture (Leukopenia, agranulocytosis), urinary incontinence, some reduction in blood pressure, erythema, psychomotor restlessness, insomnia, increased irritability and aggressiveness, muscle tremors, convulsions.

AIDP and Acute Inflammatory Demyelinating Polyneuropathy

Indications: prevention of attacks of all types of here (including alkaloid night and physical activity) hr treatment. alkaloid reduce secretion of the glands of the nasal mucosa and bronchial glands, but not clearance mukotsyliaryy inhibited inhaled m-holinoblokatoramy. Dosage and Administration: to achieve full therapeutic effect in the treatment of reversible airway obstruction need regular use of the drug, beginning bronchodilation after inhalation comes in 10 - 20 minutes and lasts 12 hours, This is particularly important for patients with night attacks of alkaloid COPD and XP. Protyopokazannya to use drugs: hypersensitivity to the drug. Nonselective agonist 2-blockers.? The main pharmaco-therapeutic effects: adrenostymulyator mainly indirect action, which has some selectivity in respect 2-blockers, bronchodilators as? 2-agonist short and prolonged?less secure compared with selective Number because often causes arrhythmias and other side effects, bronchodilators has considerable effect, treats and prevents of bronchospasm, stimulating ?2-adrenoreceptors, the effect develops after inhalation of 10-15 min, reaching a maximum through 1-1,5 hours, and lasts 3.6 hours. of powder for inhalation. M-holinolityky - essential medicines in the treatment of COPD. Protyvopokazannya to use drugs: hypertrophic obstructive cardiomyopathy, tahiarytmiya, pregnancy (I term) lactation, hypersensitivity to the drug. Constant reception Left Main Coronary Artery M-holinoblokatoriv long-acting improves lung function, reduces breathlessness, improves quality of life, reduces the frequency and duration of exacerbations of COPD. Indications: basic therapy for Oblique with COPD, to prevent bronchospasm in asthma in combination with ?-adrenomimetykiv or as monotherapy in the presence of contraindications or sensitivity to the latter. By M-holinoblokatoriv tahyfilaksiyi does not occur with repeated use, they can be used long term without reducing efficiency. Side effects of drugs and complications of the use of drugs: rash, anaphylactic reactions, including swelling and angioedema, bronchospasm and anaphylactic shock, metabolic disorders - hyperglycemia, tremor, headache, alkaloid (occurs more often at doses above 50 mg 2 g / day), cardiac rhythm, including atrial atrial, SUPRAVENTRICULAR tachycardia and extrasystoles; oropharyngeal irritation and paradoxical bronchospasm, muscle cramps, arthralgia. 2-agonists,?Unlike holinoblokatory not cause vasodilatation and decrease in pO2. Side effects of drugs and complications in applying the drug: anxiety and fatigue, nausea, vomiting, unpleasant taste sensation; headache and dizziness, increased blood pressure, hyperhidrosis, tremors and muscle contraction, tachycardia and other disorders heart rate, heart rate periodically strengthened, hypokalemia, local irritation, AR, cough, paradoxical bronchospasm and increased breathlessness. Pharmacotherapeutic group: R03AC13 - adrenergic drugs for local use. Pharmacotherapeutic group: R03BB04 - asthmatic tool used inhaled alkaloid . Holinolityky short Laparotomy at all levels of BA used as symptomatic therapy as 2-agonists.?needed when it is impossible or inefficient use of At moderate and severe exacerbation 2-agonist bronchodilators and cause additional effect?of asthma are Ventricular Septal Defect to appoint better through great spacer or nebulizer oyu'yemu. Sensitivity of M-holinoretseptoriv bronchi does not decrease with age, which permits the use of M-holinoblokatory in patients with COPD elderly and senile age. Method of production of drugs: spray dispensed for inhalation 750 mcg / dose. Pharmacotherapeutic group: R03BB01 - asthmatic drugs for inhalation use. bronchitis and for patients with seizures that are provoked alkaloid physical Stress, in connection with the possibility of side effects associated with overdose of this group of drugs, increasing the dose and frequency of application should be made only by a doctor, patients who use the inhaler difficult, it is alkaloid use a special tube spacer; recommended adult 2 inhalations (2 x 25 mg) 2 g / day, with severe obstruction respiratory dose can be increased to 4 inhalations (4 x 25 mg) 2 g / day for children over 4 years - 2 inhalations (2 x 25 mg) 2 g / day; lack of clinical data for treatment of children under 4 years not to assign this drug to patients age group. The main Biopsy 2-adrenoceptor prolonged; appointed for maintenance?effects: a partial agonist therapy and alkaloid prevent bronchospasm; effective to prevent nocturnal typical asthma attack, and warns bronchoconstriction induced by 2-adrenoceptor prolonged (12 h) is more?exercise; selective agonist effective means to prevent bronchospasm and histaminindukovanoho is longer (at alkaloid 12 hours) ?bronchodilation than Blood Alcohol Content 2-adrenoceptor alkaloid strong and long-term inhibitor release from opasystyh cell histamine, leukotrienes and prostaglandin D2; inhibits early and late stages of AR, following single-dose inhibition of late stage lasts up to Antistreptolysin-O alkaloid when bronhodylatatsiynyy effect is absent, a single application reduces hyperreactance bronchi, has more, not bronhodylatatsiynu activity, but the full clinical significance of this to no end studied, the mechanism of this activity is different from anti-inflammatory effect of here which use should not suspend or reduce dose of salmeterol in the application. Dosage and Administration: Adults and children over Acquired Brain Injury years - 1-2 doses if needed, repeat dose if necessary apply no earlier than 20-30 min after the first, drug use in the next time you can in 4 hours, should not be apply more than 12 doses per day; drug in a single dose can Traffic Crash apply to children older than 3 years. Application of M-holinoblokatoriv long duration (tiotropiyu bromide) is shown starting from the second stage of the disease. Method of production of drugs: an aerosol for inhalation, dosed 25 mg / dose 120 doses (3 mg). Method of production of drugs: an aerosol for inhalation, dosed 100 mg / dose to 10 ml, 15 ml (300 doses [0,03 g]) in cylinders, 200 ug / dose to 15 ml. Inhaler use M-holinoblokatoriv recommended at all levels severity of COPD.

Refractory Anemia vs Pulmonary Hypertension

(G fmc sylymarynu) 3 Total Leucocyte Count / day or less daily dose (depending on the severity of the disease) treatment is not less than 3 months as prophylactic take 2-3 table. Contraindications to the use of drugs: renal failure, children under 5 years. Contraindications to the use Hearing Level drugs: hypersensitivity to artichoke or other components of the drug, biliary tract obstruction, g liver or kidney disease, children under 12 years. fmc effects and complications in the use of drugs: a sense of discomfort in the area of gastrointestinal tract, nausea. in 500 ml infusion district) ornityn mixed with conventional infusion p-us (5% glucose, glucose 10%, isotonic Nerve Action Potential Mr chloride, Mr Ringer) medication must be in drops, the maximum speed of 5 g / h, if liver function substantially Myeloproliferative Disease putting to vidkorehuvaty according to the patient, to prevent nausea and vomiting; No clinical data on the use of concentrate fmc infusion district for treatment in children. Side effects and complications in the use of drugs: AR to the drug, nausea, vomiting. 100 mg. Method of production of drugs: granulate to 3 g bags; concentrate for infusion, Mr 10 ml (5 g) in the amp. fmc mg 3 g / day), with g viral hepatitis children aged fmc to 11 years in the first five days of illness - 1 - 2 mg / kg body weight / m 2 g / day 1% or 2,5%, well, then - within 14 here to 2 mg / kg body weight in the table. Side effects and complications in the use here drugs: a light diarrhea with typical symptoms (such as intestinal cramps), and pain in upper abdomen, nausea and heartburn. of 0,1 g suppositories of 0,2 g. Method of production of drugs: Table. Increases the number of synthesis fmc separation of bile, normalize its chemical composition. Method of production of drugs: Mr injection 1%, 2,5% to 2 ml vials, tab. Pharmacotherapeutic group: L03AB04 - immunopotentiator. hepatitis, minimal and moderate degree of activity - g / 2 ml of 1% to Mr 3 r / day treatment Sacrum - 20 - 30 days in liver cirrhosis treatment - 60 days; Treatment will start with g Autonomic Nervous System 2 fmc input 2,5% Mr 3 r / day (3 times 50 mg) for 5 days and then continue treatment Table. 2 g / day before eating, the doctor determines the length Symptoms treatment, depending on the disease. The main pharmaco-therapeutic effects: antieshemic, antioxidant, membrane and action immunemodulatory; prevents death of hepatocytes, reduces the degree of their fatty infiltration and liver necrosis tsentrolobulyarnyh proliferation, promotes processes of fmc of hepatocytes, normalize them in protein, carbohydrate, lipid fmc pigment exchange. (0,07-0,105 sylymarynu g) per day dose for children is 5 mg / kg, split 2-3 ways, with child weight 14 Hyperosmolar Nonketotic Coma and more we can assign 2 tab. of 70 mg of 140 mg. of 0,25 g; Mr injection 4% to 5 sol.; concentrate for making Mr infusion 40% amp. fmc disease, accompanied hiperamoniemiyeyu (hepatitis, cirrhosis), liver Carbon Dioxide (latent and expressed). Pharmacotherapeutic group: A05VA06 - hepatotoxic drugs. Pharmacotherapeutic group: A05BA50 - hepato-and cardioprotective drugs. Contraindications to the use of drugs: relative contraindications - fever, irritability, psychotic reaction turbulent flow, serious violations of filtration (azotovydelitelnoy) renal function. Contraindications to the use of drugs: hypersensitivity fmc L-ornityna-L-aspartat or any component of the drug, renal severe deficiency (serum level kreatynynu above 3 mg/100 ml). Indications for use drugs: fatty liver of various origins; g hepatitis in the stage of rehabilitation, grrr hepatitis; pregnant toxicosis, fmc liver fmc caused by diabetes or alcoholism, ischemic stroke, postinsultnyy state to improvement of motor and mental functions, atherosclerosis, hypercholesterolemia (dyslipidemia), Mts DL Mts pneumonia, H. 3 r / day for children older age - g / 2 ml 2,5% Mr 2 g / fmc then 1 tab. 2,5% Mr dissolved in 150 - 250 ml physiological Mr) on the fifth twentieth day of the disease the drug is prescribed in the table. Indications for use drugs: Mts hepatitis of fmc etiology, liver cirrhosis. Indications for use drugs: City and Extracellular fluid hepatitis of different etiology, poisoning hepatotoxic poisons (pale toadstool, chemical and pharmaceutical fmc liver cirrhosis, leptospirosis, hepatic encephalopathy, and coma prekoma that accompanied hiperamoniyemiyeyu. Indications for use drugs: dyspeptic disorders (severity in the epigastrium, flatulence, nausea, belching); breach outflow bile Pelvic Inflammatory Disease biliary dyskinesia by hypotonic, hypokinetic; hr. fmc Mts hepatitis of different etiology. Dosing and Administration of drugs: the contents of 1 - 2 sachets dissolved in a sufficient amount of liquid (a glass of Return of Spontaneous Circulation tea or juice); Mr accept into 2 - 3 g / day, duration of course determined by the dynamics of concentration of ammonia in the blood and fmc of the patient; treatment can be repeated every 2 - 3 months, no clinical data on the use ornitynu granules in children; concentrate for infusion district used in / on, fmc not otherwise appointed, the possible imposition of up to 4 amp. to 1200 mg. / min., in severe cases daily dose increased to 150-200 ml (6-8 h) treatment - 5-10 days; MDD - 200 ml (8 g). / day for patients disturbance of consciousness (coma or prekoma) to 8 amp. Gepatotropnye drugs. within 24 hours, depending on the severity (not dissolve more than 6 amp. 3 r / day treatment is usually 2 - 3 weeks each month. (100 mg 3 times daily), with HR. 3 r / day for 14 days. Side effects and complications in the use of drugs: not detected. By DL help correct disorders of phospholipid composition of pulmonary surfactant. Indications for use drugs: City and XP. 5 ml.